CrushSCI.com
227.8Average days
217Median days
52Fastest days
421Longest days
4492025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

174 days

Combining dietary fiber inulin with parathyroid hormone–lowering therapy improves bone remodeling and mechanics in a rat model of Chronic Kidney Disease–Mineral Bone Disorder

Authors
Matthew R. Allen; Corinne E. Metzger; Neal X. Chen; Shruthi Srinivasan; Kalisha O'Neill; Hannah E. Wilson; Karis L. Blacklock; Emily K. Matter; Daniel J. Stephen; Karisa M. Ecker; Ariana Moffitt; Annabel Biruete; Sharon M. MoeShow moreShow less
Affiliations
Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA; Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; Roudebush VA, Indianapolis, Indiana, USA; Department of Nutrition Science, Purdue University, West Lafayette, Indiana, USAShow moreShow less
Source PDF DOI Publisher page
339 days

Generation of a novel Slc7a9G105R mutant mouse identifies new biomarkers for cystinuria

Authors
Nirmal P. Bhatt; Theresa T.H. Nguyen; Giulia Iacono; Gabriel R. Rodriguez; Connor R.B. Anderson; Andrew Perry; Christopher K. Barlow; Dovile Anderson; Gaetan Burgio; Benjamin J. Marsland; Simon H. Jiang; Aniruddh V. Deshpande; Malcolm R. StarkeyShow moreShow less
Affiliations
Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Bladder and Kidney Health Discovery Program, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Monash Genomics and Bioinformatics Platform, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia; Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia; Monash Proteomics and Metabolomics Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia; Department of Genome and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia; Centre for Personalized Medicine, John Curtin School of Medical Research, Australian National University and Canberra Health Services, Canberra, Australian Capital Territory, Australia; Department of Nephrology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia; Centre for Kidney Research, The Children’s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia; Urology Unit, Department of Surgery, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia; School of Medical Sciences, The University of Sydney, New South Wales, AustraliaShow moreShow less
Source PDF DOI Publisher page
228 days

Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis

Authors
Muhammad Umaid Rauf; Mattia Riefolo; Ethan Wong; Janet Gilbertson; Aviva Petrie; Steven Law; Yousuf Razvi; Josephine Mansell; Awais Sheikh; Jack Carruthers; Adam Ioannou; Aldostefano Porcari; David Hutt; Dorota Rowczenio; Hawah Wurie; Sriram Ravichandran; Oliver C. Cohen; Jahanzaib Khawaja; Joshua Bomsztyk; Tamer Rezk; Ana Martinez-Naharro; Carol Whelan; Helen J. Lachmann; Ashutosh D. Wechalekar; Philip N. Hawkins; Marianna Fontana; Julian D. GillmoreShow moreShow less
Affiliations
National Amyloidosis Centre, University College London (Royal Free Campus), London, UK; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Biostatistics Unit, University College London (UCL) Eastman Dental Institute, London, UK; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, ItalyShow moreShow less
Source PDF DOI Publisher page
152 days

A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation

Authors
Thomas Drasch; Katharina A. Mayer; Georg A. Böhmig; Aylin Akifova; Fabian Halleck; Klemens Budde; David Rohlfing; Christian Hinze; Malte Kluger; Florian Grahammer; Jan Kowald; Sebastian Baatz; Stefan Reuter; Stephan Kemmner; Tobias Seibt; Mareen Pigorsch; Julia Beck; Kirsten Bornemann-Kolatzki; Ekkehard Schütz; Michael Oellerich; Bernhard Banas; Daniel ZecherShow moreShow less
Affiliations
Department of Nephrology, University Hospital Regensburg, Regensburg, Germany; Department of Medicine III, Medical University of Vienna, Vienna, Austria; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany; III. Department of Medicine and Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Division of Nephrology, Department of Endocrinology, Nephrology, and Rheumatology, University of Leipzig Medical Center, Leipzig, Germany; Department of Internal Medicine D, Transplant Nephrology, University of Muenster, Muenster, Germany; Transplant Center, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Chronix Biomedical GmbH, Göttingen, Germany; Insight Molecular Diagnostics, Nashville, Tennessee, USA; Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, GermanyShow moreShow less
Source PDF DOI Publisher page
335 days

Sex-specific shifts in CKD classification using European Kidney Function Consortium (EKFC) as compared to CKD Epidemiology (CKD-EPI) eGFR equations

Authors
Ulla T. Schultheiss; Jakob Möller; Thomas McDonnell; Toralf Melsom; Pascal Schlosser; Matthias Wuttke; Peggy Sekula; Philip A. Kalra; Bjørn O. Eriksen; Maarten W. Taal; Anna Köttgen; Kai-Uwe Eckardt; Elke Schaeffner; Inga SteinbrennerShow moreShow less
Affiliations
Institute of Epidemiology and Prevention, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany; Department of Medicine IV, Nephrology and Primary Care, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany; SYNLAB MVZ Humangenetik Freiburg GmbH, Freiburg, Germany; Donal O’Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK; Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK; Metabolic and Renal Research Group, UiT—the Arctic University of Norway, Tromsø, Norway; Section of Nephrology, Department of Medicine, University Hospital of North Norway, Tromsø, Norway; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Centre for Integrative Biological Signaling Studies (CIBSS), University of Freiburg, Freiburg, Germany; University Hospitals of Derby and Burton NHS Trust, Derby, UK; Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany; Department of Nephrology and Medical Intensive Care, Charité—Universitätsmedizin Berlin, Berlin, Germany; Institute of Public Health, Charité—Universitätsmedizin Berlin, Berlin, GermanyShow moreShow less
Source PDF DOI Publisher page
155 days

Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy

Authors
Peter D. Burbelo; Lilian Howard; Tiffany N. Caza; Dorin-Bogdan Borza; Richard W. Childs; John A. Chiorini; Meryl WaldmanShow moreShow less
Affiliations
Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA; Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA; Arkana Laboratories, Little Rock, Arkansas, USA; Department of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, USA; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does KIDNEY INTERNATIONAL take to review a manuscript?

As of 2026-11-19, CrushSCI has 15 complete review records for KIDNEY INTERNATIONAL. The fastest paper went from submission to acceptance in 52 days (CUBN-AMN pathway loss in chronic benign proteinuria, received 2026-01-27, accepted 2026-03-20); the slowest took 421 days. The average is 227.8 days and the median is 217 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.